Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Follicular Lymphoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.